BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23980508)

  • 1. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.
    Yang Q; Wu K; Ji M; Jin W; He N; Shi B; Hou P
    J Biomed Nanotechnol; 2013 Sep; 9(9):1607-16. PubMed ID: 23980508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
    Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
    Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma.
    Shi X; Yu Y; Luo M; Zhang Z; Shi S; Feng X; Chen Z; He J
    PLoS One; 2016; 11(4):e0153100. PubMed ID: 27050164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
    Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
    Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
    Zhang LY; Li PL; Wang TZ; Zhang XC
    Arch Gynecol Obstet; 2015 Oct; 292(4):891-7. PubMed ID: 25827305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.
    Liu C; Liu L; Chen X; Shen J; Shan J; Xu Y; Yang Z; Wu L; Xia F; Bie P; Cui Y; Bian XW; Qian C
    PLoS One; 2013; 8(5):e62828. PubMed ID: 23671639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of ten-eleven translocation genes in endometrial cancers.
    Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
    Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
    Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG
    Cell; 2012 Sep; 150(6):1135-46. PubMed ID: 22980977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Ishimoto T; Miyake K; Kosumi K; Harada K; Kurashige J; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Yamamoto M; Oda S; Watanabe M; Nakao M; Baba H
    Oncotarget; 2015 Sep; 6(27):23372-82. PubMed ID: 26093090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis.
    Chen Z; Shi X; Guo L; Li Y; Luo M; He J
    Oncotarget; 2017 Jan; 8(1):1944-1952. PubMed ID: 27911867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased 5-Hydroxymethylcytosine (5-hmC) predicts poor prognosis in early-stage laryngeal squamous cell carcinoma.
    Zhang Y; Wu K; Shao Y; Sui F; Yang Q; Shi B; Hou P; Ji M
    Am J Cancer Res; 2016; 6(5):1089-98. PubMed ID: 27294001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
    Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
    Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
    Kudo Y; Tateishi K; Yamamoto K; Yamamoto S; Asaoka Y; Ijichi H; Nagae G; Yoshida H; Aburatani H; Koike K
    Cancer Sci; 2012 Apr; 103(4):670-6. PubMed ID: 22320381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
    Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
    PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma.
    Qiu L; Liu F; Yi S; Li X; Liu X; Xiao C; Lian CG; Tu P; Wang Y
    J Invest Dermatol; 2018 Nov; 138(11):2388-2397. PubMed ID: 29803640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitivity 5-hydroxymethylcytosine detection in Balb/C brain tissue.
    Davis T; Vaisvila R
    J Vis Exp; 2011 Feb; (48):. PubMed ID: 21307836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
    Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
    Virchows Arch; 2019 Mar; 474(3):315-324. PubMed ID: 30554333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.
    Matsuda I; Imai Y; Hirota S
    J Clin Exp Hematop; 2014; 54(1):67-73. PubMed ID: 24942948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxymethylcytosine promotes proliferation of human uterine leiomyoma: a biological link to a new epigenetic modification in benign tumors.
    Navarro A; Yin P; Ono M; Monsivais D; Moravek MB; Coon JS; Dyson MT; Wei JJ; Bulun SE
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2437-45. PubMed ID: 25057885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer.
    Chapman CG; Mariani CJ; Wu F; Meckel K; Butun F; Chuang A; Madzo J; Bissonnette MB; Kwon JH; Godley LA
    Sci Rep; 2015 Dec; 5():17568. PubMed ID: 26631571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.